Tectonic Therapeutic, Inc. - 8-K Filing

Tectonic Therapeutic announced favorable Phase 1 safety, tolerability, and PK results for TX2100 in healthy volunteers; FDA granted Fast Track designation. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TECX

Read the full article at SEC EDGAR

More Regulatory news